TY  - JOUR
AU  - Molina-Cuadrado, Emilio
AU  - Mateo-Carrrasco, Hector
AU  - Collado, Antonio
AU  - Martin, Marta Casado
PY  - 2018
DO  - 10.1136/ejhpharm-2017-001277
SN  - 2047-9956
UR  - https://hdl.handle.net/10668/24955
T2  - European journal of hospital pharmacy
AB  - Objectives Anaemia is the most common side effect associated with ribavirin (RBV). This study intended to assess its incidence and determine its predictive factors in patients with hepatitis C virus on RBV plus direct-acting antiviral agents...
LA  - en
PB  - Bmj publishing group
KW  - Ribavirin
KW  - Direct-acting antiviral
KW  - Anaemia
KW  - Predictor
KW  - Hepatitis C
KW  - Peginterferon
KW  - Telaprevir
KW  - Therapy
KW  - Combination
KW  - Alpha-2a
TI  - Anaemia predictors in patients with chronic hepatitis C treated with ribavirin and direct-acting antiviral agents
TY  - research article
VL  - 25
ER  -